Cargando…
Personalized medicine in patients with Osteogenesis imperfecta
Autores principales: | Semler, Oliver, Hoyer-Kuhn, Heike, Doetsch, Joerg, Schoenau, Eckhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715104/ http://dx.doi.org/10.1186/2194-7791-1-S1-A10 |
Ejemplares similares
-
Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2014) -
Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2019) -
Safety and efficacy of denosumab in children with osteogenesis imperfecta - a first prospective trial
por: Hoyer-Kuhn, H., et al.
Publicado: (2016) -
Osteogenesis imperfecta—pathophysiology and therapeutic options
por: Etich, Julia, et al.
Publicado: (2020) -
Vibration-Assisted Home Training Program for Children With Spinal Muscular Atrophy
por: Stark, Christina, et al.
Publicado: (2018)